SEC Form 4 · accession 0001179110-15-009076
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Senior Vice President
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $48.90 | Jun 1, 2015 | A | 114,692 | A | Jun 1, 2016 | May 31, 2025 | Common shares | 114,692 | 114,692 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,231 on 6/1/2016, 38,230 on 6/1/2017, and 38,231 on 6/1/2018.